GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/G-POEM in Severe Refractory Gastroparesis: Gut March 2026
64

G-POEM in Severe Refractory Gastroparesis: Gut March 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated March 1, 2026

Introduction

Gastroparesis is a chronic disorder characterised by delayed gastric emptying without mechanical obstruction, leading to symptoms such as nausea, vomiting, early satiety, bloating, and postprandial fullness. Treatment options for severe and refractory gastroparesis are limited and often ineffective.

Gastric per-oral endoscopic pyloromyotomy (G-POEM) is a minimally invasive endoscopic technique that divides pyloric muscle fibres to improve gastric emptying. Although observational studies have shown promising results, high-quality randomised evidence has been limited.

Summary

This randomised sham-controlled pilot trial evaluated the efficacy of G-POEM in severe gastroparesis.

A total of 41 patients with refractory gastroparesis (diabetic, postsurgical, or idiopathic) were randomised to G-POEM (n=21) or sham procedure (n=20). The primary endpoint was treatment success, defined as a ≥50% reduction in the Gastroparesis Cardinal Symptom Index (GCSI) at 6 months.

Key findings:

Treatment success:

71% with G-POEM vs 22% with sham (p = 0.005)

By aetiology:

Diabetic gastroparesis: 89% response

Postsurgical gastroparesis: 50% response

Idiopathic gastroparesis: 67% response

Gastric emptying:

Median 4-hour gastric retention improved from 22% to 12% after G-POEM,

No significant change after sham.

Crossover results:

Among 12 sham patients crossing over to G-POEM, 75% achieved symptom improvement.

Clinical Takeaway

This sham-controlled randomised trial demonstrates that G-POEM significantly improves symptoms and gastric emptying in severe refractory gastroparesis, particularly in diabetic cases. However, results remain less conclusive in idiopathic and postsurgical gastroparesis, and larger trials are required to confirm long-term benefits.

Related Q&A

65

Colon Capsule Endoscopy vs Conventional Colonoscopy After Diverticulitis- Endoscopy | March 2026. DOI: 10.1055/a-2695-6904

Introduction After CT-confirmed diverticulitis, follow-up colonoscopy is routinely performed to exclude malignancy. Colon capsule endoscopy (CCE) offers a non-invasive alternative, but its impact on patient experience remains unclear....

66

METARSI Trial: Endoscopy International Open, Feb.26

The METARSI trial is a prospective, multicenter randomised controlled study comparing partially covered self-expanding metal stents (PC-SEMS) versus uncovered SEMS (U-SEMS) in patients with malignant unresectable distal biliary...

67

EUS-Directed Transgastric ERCP (EDGE) in RYGB: GIE, Feb.26

Endoscopic ultrasound–directed transgastric ERCP (EDGE) has emerged as a transformative technique for managing biliary and pancreatic diseases in patients with Roux-en-Y gastric bypass (RYGB) anatomy. Traditional ERCP is...

68

Linaclotide Administration plus PEG for Colonoscopy Bowel Preparation- AJG Feb.26

High-volume polyethene glycol (PEG) solutions remain a major barrier to successful colonoscopy bowel preparation because of poor tolerability. Linaclotide, a guanylate cyclase-C agonist that increases intestinal secretion and...

69

SOCCER Trial: Forceps Boost Cannulation Success in Difficult ERCP- AJG Feb.26

Introduction Difficult biliary cannulation remains one of the most common and consequential problems in ERCP. Failed cannulation drives repeat procedures, percutaneous or surgical rescue, higher costs, longer hospital...

70

Robot-Assisted Gastric ESD Is Feasible and Safe-Endoscopy Feb.26

Introduction Endoscopic submucosal dissection (ESD) is the preferred curative treatment for early gastric cancer, but it remains technically demanding, largely because of poor traction and limited visualization during...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer